Published in J Invest Dermatol on April 01, 1994
Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc Natl Acad Sci U S A (1998) 2.44
Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med (2002) 1.83
Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol (1998) 1.75
Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair. J Invest Dermatol (2009) 1.64
Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV. EMBO J (1998) 1.55
UV as an amplifier rather than inducer of NF-kappaB activity. Mol Cell (2008) 1.52
Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release. J Clin Invest (1995) 1.49
Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes. Proc Natl Acad Sci U S A (1996) 1.28
Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients. J Cancer Res Clin Oncol (2007) 1.20
Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation. Proc Natl Acad Sci U S A (1999) 1.16
Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice. J Exp Med (1996) 1.14
The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc Natl Acad Sci U S A (1997) 1.11
Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy. Br J Cancer (1996) 1.07
A role for NF-kappaB-dependent gene transactivation in sunburn. J Clin Invest (2000) 1.01
Protein kinases and transcription factors activation in response to UV-radiation of skin: implications for carcinogenesis. Int J Mol Sci (2011) 1.00
Down-regulation of interferon gamma-activated STAT1 by UV light. Proc Natl Acad Sci U S A (1997) 0.99
UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription. J Invest Dermatol (2008) 0.95
Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells. Nucleic Acids Res (1996) 0.95
Linking JNK Activity to the DNA Damage Response. Genes Cancer (2013) 0.89
Constitutive and UV-B modulated transcription of Nod-like receptors and their functional partners in human corneal epithelial cells. Mol Vis (2008) 0.89
Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment. Transfusion (2009) 0.82
Protective effect of the isoflavone equol against DNA damage induced by ultraviolet radiation to hairless mouse skin. J Vet Sci (2006) 0.80
The contribution of Langerhans cells to cutaneous malignancy. Trends Immunol (2010) 0.79
12(S)-Hydroxyheptadeca-5Z,8E,10E-trienoic acid suppresses UV-induced IL-6 synthesis in keratinocytes, exerting an anti-inflammatory activity. Exp Mol Med (2012) 0.79
Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer. Prog Lipid Res (2016) 0.78
Detection of UV-induced activation of NF-kappaB in a recombinant human cell line by means of Enhanced Green Fluorescent Protein (EGFP). Radiat Environ Biophys (2007) 0.76
Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today (1998) 3.12
Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1. J Immunol (1982) 2.90
Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF). J Immunol (1981) 2.74
Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell (2000) 2.70
Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med (1990) 2.62
Impaired sodium excretion, decreased glomerular filtration rate and elevated blood pressure in endothelin receptor type B deficient rats. J Mol Med (Berl) (2001) 2.55
Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol (2006) 2.49
Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am J Respir Cell Mol Biol (2000) 2.35
Infiltrates in protocol biopsies from renal allografts. Am J Transplant (2007) 2.24
Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis (2001) 2.14
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Br J Dermatol (2010) 2.12
Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol (1983) 2.03
Asymmetry pays: visual lateralization improves discrimination success in pigeons. Curr Biol (2000) 1.92
Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol Today (1995) 1.91
Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol (1999) 1.81
Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol (1998) 1.75
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J Virol (1993) 1.64
Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension. Br J Dermatol (2008) 1.64
Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy. Br J Dermatol (2013) 1.63
Tonsillectomy does not prevent a progressive course in IgA nephropathy. Clin Nephrol (1999) 1.60
IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol (1989) 1.54
Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Drug Metab Dispos (2009) 1.53
Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. Mol Cell Biol (1995) 1.51
Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release. J Clin Invest (1995) 1.49
Evidence for an epidermal cytokine network. J Invest Dermatol (1990) 1.48
Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thromb Haemost (1991) 1.46
The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant (2010) 1.43
[Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients]. Hautarzt (2004) 1.42
Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol (1990) 1.42
[Drug reaction to amoxicillin simulating toxic pustuloderma]. Hautarzt (1991) 1.42
Molecular mechanisms of UV-induced apoptosis. Photodermatol Photoimmunol Photomed (2000) 1.41
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Diagnosis of bone infection using 99m Tc-HMPAO labelled leukocytes. Nucl Med Commun (2001) 1.40
Psoriasis vulgaris treated successfully with mycophenolate mofetil. Br J Dermatol (1998) 1.40
Treatment of urticaria pigmentosa using interferon alpha. Br J Dermatol (1995) 1.40
Valve surgery combined with coronary artery operation: is the use of internal mammary artery a predictor for early complications? Eur J Cardiothorac Surg (1996) 1.39
The tell-tale urinary chloride. Nephrol Dial Transplant (2001) 1.39
Validation of Dermaphot(®) for the assessment of steroid-induced skin atrophy. Arch Dermatol Res (2012) 1.38
Analgesic nephropathy. Nephrol Dial Transplant (1996) 1.38
Bite forces in patients after treatment of mandibular angle fractures with miniplate osteosynthesis according to Champy. Int J Oral Maxillofac Surg (2002) 1.38
Responder cells in the human autologous mixed lymphocyte reaction. J Clin Invest (1981) 1.37
Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture. J Clin Invest (1982) 1.33
Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas. Eur J Nucl Med (1988) 1.32
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest (1994) 1.29
Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J Biol Chem (1999) 1.29
Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol (2008) 1.28
IFN-beta 2/IL-6 augments the activity of human natural killer cells. J Immunol (1989) 1.28
In vitro correction of the interleukin 2 defect of autoimmune mice. Eur J Immunol (1983) 1.27
Increased thymocyte-activating factor in human gingival fluid during gingival inflammation. Infect Immun (1982) 1.27
99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results. Nucl Med Commun (1989) 1.25
The expression and modulation of IL-1 alpha in murine keratinocytes. J Immunol (1988) 1.25
Mycosis fungoides: a dermatological masquerader. Br J Dermatol (2007) 1.24
Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol (1995) 1.24
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
Reliability of drug history in analgesic users. Lancet (1984) 1.21
Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost (1988) 1.21
Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol (1995) 1.20
No enhanced influenza virus resistance of murine and avian cells expressing cloned duck Mx protein. Virology (1993) 1.18
Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med (2001) 1.17
Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J Invest Dermatol (1991) 1.17
Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulin. J Biol Chem (1989) 1.17
Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation. Proc Natl Acad Sci U S A (1999) 1.16
Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology (1994) 1.16
UV-irradiated epidermal cells produce a specific inhibitor of interleukin 1 activity. J Immunol (1987) 1.15
A Dictyostelium mutant with severe defects in alpha-actinin: its characterization using cDNA probes and monoclonal antibodies. J Cell Sci (1988) 1.15
Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation. J Immunol (1990) 1.14
In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J Invest Dermatol (1994) 1.14
Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies. Am J Transplant (2007) 1.13
Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J Immunol (2000) 1.13
Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance. J Invest Dermatol (1996) 1.13
Amines and a peptide as neurohormones in lobsters: actions on neuromuscular preparations and preliminary behavioural studies. J Exp Biol (1980) 1.13
Effects of endothelin receptor antagonists on the progression of diabetic nephropathy. Nephron (2001) 1.12
Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line. J Invest Dermatol (1983) 1.12